Literature DB >> 6218181

T lymphocyte subsets in autoimmune thyroid diseases and subacute thyroiditis detected with monoclonal antibodies.

Y Iwatani, N Amino, H Mori, S Asari, Y Izumiguchi, Y Kumahara, K Miyai.   

Abstract

Peripheral T lymphocyte subsets were analysed with monoclonal antibodies, by highly standardized fluorescence-activated cell sorter analysis instead of manual counting by the indirect immunofluorescence method, in autoimmune thyroid diseases and subacute thyroiditis. Total lymphocyte counts were increased in patients with thyrotoxic Graves' disease and subacute thyroiditis. The percentage of total T (Leu 1) cells was significantly lower in patients with thyrotoxic Graves' disease and Hashimoto's disease with destructive thyrotoxicosis than in normal subjects. No significant changes were observed in the percentages of suppressor-cytotoxic T (Leu 2a) cells or helper-inducer T (Leu 3a) cells or in the Leu 3a-Leu 2a ratio in different groups of patients. There were no correlations between the percentages of E rosette-forming cells and Leu 1 cells and between the percentages of T gamma cells and Leu 2a cells in normal subjects and patients. The peak position of fluorescence intensity of Leu 2a cells showed a significant sex difference even in normal controls. The most important finding was a significant decrease in the peak position of Leu 2a cells in patients with thyrotoxic Graves' disease and with hypothyroid or thyrotoxic Hashimoto's disease. These findings indicate the significant association of qualitative, but not quantitative, abnormality of suppressor-cytotoxic T (Leu 2a) cells with thyroid dysfunction in autoimmune thyroid diseases.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6218181     DOI: 10.1210/jcem-56-2-251

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

1.  Surface expression and release of soluble forms of CD8 and CD23 in CD40- and IL-4-activated mononuclear cells from patients with Graves' disease (GD).

Authors:  M Itoh; K Uchimura; N Hayakawa; M Makino; R Hayashi; M Nagata; H Kakizawa; A Nagasaka; H Sakamoto; H Kuzuya
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

Review 2.  The haematology of hyperthyroidism: abnormalities of erythrocytes, leucocytes, thrombocytes and haemostasis.

Authors:  H C Ford; J M Carter
Journal:  Postgrad Med J       Date:  1988-10       Impact factor: 2.401

3.  Marked increase of CD5 + B cells in hyperthyroid Graves' disease.

Authors:  Y Iwatani; N Amino; T Kaneda; K Ichihara; H Tamaki; J Tachi; F Matsuzuka; S Fukata; K Kuma; K Miyai
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

4.  Quantitative immunological differences between newly diagnosed Graves' disease patients and relapsed patients.

Authors:  U Di Mario; F P Cavatorta; R Perfetti; G Pugliese; P Pozzilli; J Sutherland; M Vitillo; D Andreani
Journal:  J Endocrinol Invest       Date:  1988-02       Impact factor: 4.256

5.  Endocrine regulation of the immune system.

Authors:  W Kiess; B H Belohradsky
Journal:  Klin Wochenschr       Date:  1986-01-02

6.  Decrease of peripheral large granular lymphocytes in Graves' disease.

Authors:  Y Iwatani; N Amino; O Kabutomori; H Mori; H Tamaki; S Motoi; Y Izumiguchi; K Miyai
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

7.  The Association Between Chronic Lymphocytic Thyroiditis and the Progress of Papillary Thyroid Cancer.

Authors:  Inhwa Lee; Hyeung Kyoo Kim; Euy Young Soh; Jeonghun Lee
Journal:  World J Surg       Date:  2020-05       Impact factor: 3.352

8.  Analysis of T cell subsets in Graves' disease: alterations associated with carbimazole.

Authors:  M E Ludgate; A M McGregor; A P Weetman; S Ratanachaiyavong; J H Lazarus; R Hall; G W Middleton
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-18

9.  Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP).

Authors:  R M Talaat; A M Elmaghraby; S S Barakat; M El-Shahat
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

10.  Autoimmune thyroid disease: purification and phenotypic analysis of intrathyroid T cells.

Authors:  G W Canonica; M Caria; G Torre; A Risso; M E Cosulich; M Bagnasco
Journal:  J Endocrinol Invest       Date:  1984-12       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.